ClinicalTrials.gg
RecruitingNCT04142177SCEPTERUpdated May 4, 2026

Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response

An interventional study of Pain EASE and Tailored exercise in Chronic Low Back Pain, sponsored by VA Office of Research and Development. Recruiting at 19 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-04.

Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jun 2022; still recruiting 4 years 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
2,529
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 18 studies in Low Back Pain by VA Office of Research and Development — 5 open to participants now, 5 under way, none of them phase 3. Low Back Pain · VA Office of Research and Development.

Planned enrollment
Largest of 15
2,529 · median 152
Started
2022
with 3 others
No phase
14 of 18
2 open now
Registered
11th of 18
by date

Among the 18 studies in Low Back Pain by VA Office of Research and Development, this one has the largest planned enrollment of the 15 interventional ones that give a count, is one of 4 that started in 2022, is one of 14 with no phase, and was the 11th registered.

Low Back Pain

2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.

Browse Low Back Pain studies →

Open to participants now

5 of the 18 studies in Low Back Pain by VA Office of Research and Development are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 18 studies in Low Back Pain by VA Office of Research and Development, or all of them as a file.
02

Study summary

VETERANS ONLY. Chronic low back pain (cLBP) is common. Most Americans will have at least one episode of low back pain in their lifetimes. Approximately 50% of all US Veterans have chronic pain, and CLBP is the most common type of pain in this population. This study will use a sequential randomized, pragmatic, 2-step comparative effectiveness study design. The main goal is to identify the best approach for treating cLBP using commonly recommended non-surgical and non-pharmacological options. The first step compares continued care and active monitoring (CCAM) to internet-based pain self-management (Pain EASE) and an enhanced physical therapy intervention that combines Pain EASE with tailored exercise and physical activity. Patients who do not have a significant decrease in pain interference (a functional outcome) in Step 1 and those desiring additional treatment will be randomized in Step 2 to yoga, spinal manipulation therapy (SMT), or therapist-delivered cognitive behavioral therapy (CBT). Participants proceeding to randomization in Step 2 will be allowed to exclude up to one of the three Step 2 treatments based on their preferences. The investigators' primary hypothesis for the first treatment step is that an enhanced physical therapy intervention that combines pain self-management education with a tailored exercise program will reduce pain interference greater than internet-based pain self-management alone or CCAM in Veterans with cLBP. The primary outcome is change in pain interference at 3 months, measured using the Brief Pain Inventory (BPI) pain interference subscale. Study participants will be followed for one year after initiation of their final study treatments to assess the durability of treatment effects. The study plans to randomize 2529 patients across 20 centers.

Read the detailed description

Chronic low back pain (cLBP) is common. The point prevalence of low back pain in the US is about 25%, and the majority of Americans will have at least one episode of low back pain in their lifetimes. Approximately 50% of all US Veterans have chronic pain, and cLBP is the most common type of pain in this population. Low back pain is the second most common condition leading patients to seek a physician's care. In addition, cLBP is costly. Healthcare expenditure for low back pain in the US is greater than $30 billion per year, and total expenditures including the cost of disability approach $100 billion per year. In fact, low back pain is the most common cause of work-related disability and is a major cause of service- connected disability amongst US Veterans. Making matters worse, the US is in the midst of a growing opioid abuse epidemic having its roots in the lack of understanding of how to effectively treat cLBP and other common forms of acute and chronic pain.

Using a sequential randomized, pragmatic, 2-step comparative effectiveness study design, the main goal is to identify the optimal approach to cLBP treatment employing commonly recommended non-surgical, non-pharmacological options. Options for treatment in this trial were selected based on the VA's stepped-care model for the treatment of chronic pain, availability of treatments, controversies in current clinical practice, and the surveyed preferences of both Veterans with cLBP and VA healthcare providers. The implementation of study results has been kept closely in mind, and stakeholder input has been incorporated.

The first step compares continued care and active monitoring arm (CCAM) to internet-based pain self-management (Pain EASE) and an enhanced physical therapy intervention that combines Pain EASE with tailored exercise and physical activity. The utility of tailored exercise requiring physical therapist guidance added to internet-based self-management has not been examined. A CCAM arm is included in this step to definitively assess the effectiveness of these initial treatment options. Patients failing to achieve clinically significant reductions in pain interference (a functional outcome) in Step 1 and those desiring additional treatment will be randomized in Step 2 to yoga, spinal manipulation therapy (SMT), or therapist-delivered cognitive behavioral therapy (CBT). These options appear in consensus guidelines although little information is available to help patients and providers select the most effective option. Each option has a distinct theoretical basis for effectiveness with yoga described as a mind-body therapy, SMT as a technique to adjust the structural relationships of the spine, and CBT as a psychological or behavioral approach. While the literature suggests approximate clinical equipoise between these treatments, costs, side effects, access to specific options and patient/provider acceptance may differ significantly. Participants proceeding to randomization in Step 2 will be allowed to exclude up to one of the three Step 2 treatments based on their preferences.

The investigators' primary hypothesis corresponding to the first treatment step is that an enhanced physical therapy intervention that combines pain self-management education with a tailored exercise program will reduce pain interference greater than internet-based pain self-management alone or CCAM in Veterans with cLBP. For the second step, the study has been powered to detect clinically meaningful pairwise differences among the three treatments. The primary outcome is change in pain interference at 3 months, measured using the Brief Pain Inventory (BPI) pain interference subscale. This is a widely accepted functional outcome in musculoskeletal pain trials and emphasizes an endpoint important to patients, providers and healthcare management systems. Study participants will be followed for one year after initiation of their final study treatments to assess the durability of treatment effects.

The investigators will leverage the power of this large study and maximize its impact by incorporating additional outcome measures as recommended by the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) consortium and other pain trials consensus groups. These secondary outcomes include pain severity, physical functioning, depression, anxiety, fatigue, sleep, global impression of change, and quality of life. The investigators will evaluate the impact of patient characteristics, treatment preferences and expectations on study outcomes as these variables have been identified in smaller studies to modify treatment response. To derive information rapidly translatable to changes in VA care, the investigators will collect information critical for implementation of the treatment strategies under study. Key implementation factors will include treatment fidelity, treatment adherence, patient acceptance, provider acceptance, logistical feasibility, and resource requirements. Finally, a carefully designed costs and downstream budget impact aim will provide additional practical information for clinical managers and policy makers related to non-pharmacological treatments for cLBP.

The study will involve diverse VA centers with respect to geographical region, racial characteristics of the population served and facility size. The study plans to randomize 2529 patients across 20 centers. Preliminary site surveys indicate a high level of enthusiasm for the project. In addition, a query of the VA's Corporate Data Warehouse (CDW) identified more than 850,000 potential cLBP study subjects receiving regular care through VA. Twenty-five VA medical centers have more than 10,000 potentially eligible patients underscoring the high prevalence of cLBP. The investigators' pragmatic trial design will incorporate broad eligibility criteria.

Chronic low back pain is an enormous problem for the VA, the United States and many other countries. This study will provide definitive information concerning the effectiveness, costs, acceptability, and implementation of several commonly used, patient-preferred, non-pharmacological treatment options. All the selected treatment options carry relatively low levels of risk, are guideline congruent, and are consistent with stepped-care models of healthcare delivery used by the VA and other healthcare organizations. The impact on VA healthcare is expected to be large and immediate.

03

Conditions studied

  • Chronic Low Back Pain

Keywords

  • chronic low back pain
  • severe low back pain
  • pain
  • non-pharmacological treatment
  • self-management
  • physical therapy
  • exercise
  • yoga
  • cognitive behavioral therapy
  • spinal manipulation therapy
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

To be eligible to participate in this study, an individual must meet all the following criteria:

  1. Low back pain

    1. present for at least 6 months,
    2. present most days or everyday,
    3. interferes the most with activities considering all of the places where the patient experiences pain;
  2. Pain, Enjoyment, General Activity (PEG) score of 4 or greater;
  3. Veteran age 18 years or older, either sex, any racial or ethnic background;
  4. Able to comprehend and willing to sign the study form;
  5. Able and willing to attend in-person treatment sessions;
  6. Anticipate continuing care at the enrolling VA for the period of the study;
  7. Stable access to the internet at home, work, or other location (e.g. mobile phone), and an email address.

Exclusion criteria

Exclusion Criteria:

An individual who meets any of the following criteria will be excluded from participation in this study:

  1. Currently enrolled in any other interventional study unless exempted by CSP;
  2. Acute or chronic illness that would prevent the Veteran from receiving study treatments offered (e.g., uncontrolled hypertension, recent myocardial infarction within the last 6 months, unstable angina, acute congestive heart failure);
  3. Neurological impairment related to disease of the spine or other causes preventing participation in any of the treatment modalities under study;
  4. Current or recent (last 3 months) treatment involving Cognitive Behavioral Therapy, Spinal manipulation therapy, or Yoga;
  5. Current severe alcohol or substance abuse use disorder;
  6. Severe psychiatric illness (e.g. current psychosis, current suicidal ideation, or psychiatric illness requiring hospitalization within the last 6 months);
  7. Back surgery within the last 6 months, or undergoing evaluation for back surgery or planned back surgery;
  8. Cognitive or severe hearing or visual impairment preventing participation in treatment options or outcome measure assessments;
  9. Pregnancy
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Sequential assignment
Masking
Single (Outcomes assessor)
Enrollment
2,529 participants (estimated)

Study arms

  • Active comparator
    Internet-based pain self-management program

    Internet-based treatment (Step 1 Treatment)

    Other: Pain EASE

  • Active comparator
    Enhanced Physical Therapy

    Intervention that combines the internet-based pain self-management program with tailored exercise and physical activity guided by a physical therapist (Step 1 treatment)

    Other: Pain EASE · Procedure: Tailored exercise

  • Placebo comparator
    Continued Care and Active Monitoring (CCAM)

    CCAM will not be standardized keeping in line with the pragmatic nature of this trial. CCAM may be variable across sites and for individual participants reflecting de facto clinical practice for cLBP. Clinical practice may involve pharmacological and non-pharmacological treatments for cLBP. Current analgesics (including opioids, acetaminophen, NSAIDs, topical analgesics (capsaicin), serotonin-norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants, skeletal muscle relaxants, and alpha-2-delta ligands (gabapentin-like drugs)) and non-pharmacological treatments may be continued by participants. CCAM participants will be encouraged to discuss pain problems with their treating physician, but not begin new treatments if possible. Patients will specifically be discouraged from starting CBT, chiropractic, or yoga. Other than this, there will be no attempt by study personnel to influence pain management (Step 1 Treatment)

    Other: Continued Care and Active Monitoring

  • Active comparator
    Cognitive Behavioral Therapy (CBT)

    Participants randomized to CBT in Step 2 will receive treatment with a trained therapist using the VA's CBT-chronic pain (CBT-CP) protocol involving one planning session and 9 treatment sessions (10 total) over 3 months (Step 2 Treatment).

    Behavioral: Cognitive Behavioral Therapy (CBT)

  • Active comparator
    Spinal Manipulation Therapy (SMT)

    After examination by a qualified Doctor of Chiropractic (DC), a SMT intervention consisting of up to 10 sessions over 3 months will be designed focusing on spinal manipulation and/or mobilization of the lower thoracic, lumbar and/or sacroiliac joints. Adjunctive use of myofascial and/or stretching techniques are allowed as they are commonly used along with SMT, and can be considered a standard accompaniment to SMT (Step 2 Treatment).

    Procedure: Spinal Manipulation Therapy (SMT)

  • Active comparator
    Yoga

    The Yoga for Veterans with cLBP program consists of up to 10 weekly, 60-minute instructor-led sessions along with 15-20 minutes of yoga practiced at home each non-session day. The initial session is 75 minutes (15 minutes longer than the other sessions). The yoga program can be considered classical hatha yoga with influences from Iyengar and Viniyoga yoga. These styles emphasize modifications and adaptations including the use of props such as straps and blocks to minimize the risk of injury and make the poses accessible to people with health problems and limitations (Iyengar, 1979). The instructor leads participants through a series of 23 yoga poses (32 total variations) at a slow-moderate pace (Step 2 Treatment).

    Procedure: Yoga

Interventions

  • OtherPain EASE

    The internet-based pain self-management program consists of open access to the Pain EASE program (Pain E-health for Activity, Skills, and Education) for the duration of participation in the trial. Pain EASE has 10 pain coping skill modules: pain education, setting personal goals, planning meaningful activities, physical activity (stretching, body mechanics, and a pedometer-based walking program), relaxation, developing healthy thinking patterns, pacing and problem-solving, improving sleep, effective communication, and future planning.

  • ProcedureTailored exercise

    Findings from the initial examination and the Keele STarT Back Screening Tool (Hill, et al., 2011) will be used by the physical therapist to guide and tailor the intervention to individual participants which will involve up to 8 treatment sessions with ongoing home exercise. For most participants, exercise and physical activity will focus on walking in addition to motor control and stabilization exercises for the low back with flexibility exercises when lumbar spine stiffness is present.

  • OtherContinued Care and Active Monitoring

    CCAM will not be standardized keeping in line with the pragmatic nature of this trial. CCAM may be variable across sites and for individual participants reflecting de facto clinical practice for cLBP. Clinical practice may involve pharmacological and non-pharmacological treatments for cLBP. Current analgesics (including opioids, acetaminophen, NSAIDs, topical analgesics (capsaicin), serotonin-norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants, skeletal muscle relaxants, and alpha-2-delta ligands (gabapentin-like drugs)) and non-pharmacological treatments may be continued by participants. CCAM participants will be encouraged to discuss pain problems with their treating physician, but not begin new treatments if possible. Patients will specifically be discouraged from starting CBT, chiropractic, or yoga. Other than this, there will be no attempt by study personnel to influence pain management.

  • BehavioralCognitive Behavioral Therapy (CBT)

    Participants randomized to CBT in Step 2 will receive treatment with a trained therapist using the VA's CBT-chronic pain (CBT-CP) protocol involving one planning session and 9 treatment sessions (10 total) over 3 months. The VA's CBT-CP protocol consists of 11 core CBT-CP modules that can be completed in up to 10 sessions. Weekly, individual sessions of 45-50 minutes are recommended, although it is recognized that bi-weekly or other arrangements are often made to fit practical needs.

  • ProcedureSpinal Manipulation Therapy (SMT)

    After examination by a qualified Doctor of Chiropractic (DC), a SMT intervention consisting of up to 10 sessions over 3 months will be designed focusing on spinal manipulation and/or mobilization of the lower thoracic, lumbar and/or sacroiliac joints. Adjunctive use of myofascial and/or stretching techniques are allowed as they are commonly used along with SMT, and can be considered a standard accompaniment to SMT.

  • ProcedureYoga

    The Yoga for Veterans with cLBP program consists of up to 10 weekly, 60-minute instructor-led sessions along with 15-20 minutes of yoga practiced at home each non-session day. The initial session is 75 minutes (15 minutes longer than the other sessions). The yoga program can be considered classical hatha yoga with influences from Iyengar and Viniyoga yoga. These styles emphasize modifications and adaptations including the use of props such as straps and blocks to minimize the risk of injury and make the poses accessible to people with health problems and limitations (Iyengar, 1979). The instructor leads participants through a series of 23 yoga poses (32 total variations) at a slow-moderate pace.

06

What researchers measure

Primary outcomes

  1. Brief Pain Inventory (BPI) Interference scale

    Pain interference will be assessed with the Brief Pain Inventory (BPI) Interference subscale, a validated measure that rates pain interference of pain on 7 items (mood, physical activity, work, social activity, relations, sleep, and life enjoyment). BPI scores range 0 to 10, with higher scores representing worse pain interference, and a 1-point change considered clinically important. Linear mixed effects models will be used to compare the primary outcome (change in pain interference score from pre-treatment to 3 months after treatment) between Step 1 treatments in all participants and between Step 2 treatments in Step 1 non-responders. The mixed effects model will include treatment and study site as fixed effects, and therapist as random effects. For the comparison of Step 1 treatments, the model will also include a fixed effect for opioid use at study entry.

    Time frame: 3 months post-treatment

Secondary outcomes

  1. Serious Adverse Events

    Attributable and possibly attributable serious adverse events

    Time frame: 3, 6, 9, and 12 months post-treatment

  2. Brief Pain Inventory (BPI) Interference scale

    Pain interference will be assessed with the Brief Pain Inventory (BPI) Interference subscale, a validated measure that rates pain interference of pain on 7 items (mood, physical activity, work, social activity, relations, sleep, and life enjoyment). BPI scores range 0 to 10, with higher scores representing worse pain interference, and a 1-point change considered clinically important.

    Time frame: 6, 9, and 12 months post-treatment

  3. Patient Health Questionnaire-9 (PHQ-9)

    This is a tool to measure comorbid depression. This scale is frequently used in VA settings, has been well validated, and is a quick self-administered questionnaire. \- Possible range for PHQ-9 is 0-27. Higher scores indicate more severe depression. 0-4: None/Minimal depression, 5-9: Mild depression, 10-14: Moderate depression, 15-19: Moderately severe depression, 20-27: Severe depression.

    Time frame: 3, 6, 9, and 12 months post-treatment

  4. Numeric Rating Scale (NRS)

    Possible range of NRS is 0 to 10 with higher scores reflecting greater perceived pain.

    Time frame: 3, 6, 9, and 12 months post-treatment

  5. Roland-Morris Disability Questionnaire (RMDQ)

    Roland-Morris Disability Questionnaire (RMDQ) measures low-back specific physical function. The RMDQ consists of 24 statements (e.g., "I stay at home most of the time because of my back and/or leg pain") that respondents simply endorse "yes" or "no." \- Possible range of RMDQ is 0-24 with higher scores reflecting greater perceived disability.

    Time frame: 3, 6, 9, and 12 months post-treatment

  6. Generalized Anxiety Disorder-7 Scale (GAD-7)

    This is a self-administered tool to assess anxiety. \- Possible range for GAD-7 is 0-21. Higher scores indicate more severe anxiety symptoms. 0-4: None/Minimal anxiety; 5-9: Mild Anxiety; 10-14: Moderate Anxiety; 15-21: Severe anxiety.

    Time frame: 3,6, 9, and 12 months post-treatment

  7. Patient-Reported Outcomes Measurement Information System (PROMIS) - Sleep

    Patient-Reported Outcomes Measurement Information System (PROMIS) 4-item sleep scale assesses perceptions of sleep quality, sleep depth, and restorative sleep. \- Possible range for PROMIS 4-item sleep scale is 4 to 20. The scale has five response options (e.g., 1 = not at all to 5 = very much) with higher scores indicating more sleep disturbance.

    Time frame: 3, 6, 9, and 12 months post-treatment

  8. Patient-Reported Outcomes Measurement Information System (PROMIS) - Fatigue

    To assess fatigue, the PROMIS 4-item fatigue scale will be used. Possible range for PROMIS 4-item fatigue scale is 4-20. The scale has five response options (e.g., 1 = not at all to 5 = very much), with higher scores indicating worse fatigue.

    Time frame: 3, 6, 9, and 12 months post-treatment

  9. Global Mental Health (GMH-2)

    To assess mental health, the two-item Global Mental Health (GMH-2) scale will be used. Possible range for GMH-2 is 2-10. The scale has five response options (e.g. 1 = excellent to 5 = poor), with higher scores indicating worse mental health.

    Time frame: 3, 6, 9, and 12 months post-treatment

  10. Global Physical Health (GPH-2)

    To assess physical health, the two-item Global Physical Health (GPH-2) scale will be used. Possible range for GPH-2 is 2-10. The scale has five response options (e.g. 1 = excellent to 5 = poor), with higher scores indicating worse physical health.

    Time frame: 3, 6, 9, and 12 months post-treatment

  11. Patient Global Impression of Change (PGIC)

    This is a single-item 7-point scale that captures a patient's rating of overall improvement.

    Time frame: 3,6, 9, and 12 months post-treatment

  12. EuroQol Quality of Life Scale (EQ-5D-5L)

    This is a 5-question generic health status measure to assess level of impairment in mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. In addition, the scale has a 20cm Visual Analog Scale to assess overall self-rated health status.

    Time frame: 3, 6, 9, and 12 months post-treatment

  13. Non-VA Healthcare Utilization

    medical care obtained outside of the VA

    Time frame: 3, 6, 9, and 12 months post-treatment

  14. Societal Cost

    overall costs to the participant and others

    Time frame: 3, 6, 9, and 12 months post-treatment

  15. Follow-up Treatments and Medications

    medications and non-study treatment for back pain

    Time frame: 3, 6, 9, and 12 months post-treatment

07

Study locations

13 of 19 sites recruiting
  • Phoenix VA Health Care System, Phoenix, AZ
    Phoenix, Arizona 85012, United States
    Recruiting
    • Aram Mardian, MD · Contact602-277-5551
  • VA Loma Linda Healthcare System, Loma Linda, CA
    Loma Linda, California 92357-1000, United States
    Recruiting
    • Thomas Edell, MD · Contact909-801-5127
  • VA Long Beach Healthcare System, Long Beach, CA
    Long Beach, California 90822, United States
    Recruiting
    • Douglas Priestley, MD · Contact714-914-3853
  • VA Palo Alto Health Care System, Palo Alto, CA
    Palo Alto, California 94304-1207, United States
    Recruiting
    • Mitchell J Wong, MD · ContactMitchell.Wong@va.gov · 650-493-5000
    • David J Clark, PhD MD · Study chair
  • Rocky Mountain Regional VA Medical Center, Aurora, CO
    Aurora, Colorado 80045, United States
    Withdrawn

    Not enrolling at this site.

  • Bay Pines VA Healthcare System, Pay Pines, FL
    Bay Pines, Florida 33744-0000, United States
    Terminated

    Not enrolling at this site.

  • Orlando VA Healthcare System, Orlando, FL
    Orlando, Florida 32827, United States
    Recruiting
    • Charles Penza, PhD · Contact407-631-3190
  • Atlanta VA Medical and Rehab Center, Decatur, GA
    Decatur, Georgia 30033-4004, United States
    Recruiting
    • Jerry Kalangara, MD · Contact404-329-2201
  • Richard L. Roudebush VA Medical Center, Indianapolis, IN
    Indianapolis, Indiana 46202-2884, United States
    Recruiting
    • David Haggstrom, MD · Contact317-988-2067
  • Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
    Baltimore, Maryland 21201, United States
    Terminated

    Not enrolling at this site.

  • VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
    Boston, Massachusetts 02130-4817, United States
    Recruiting
    • Eduardo Lopez, MD · Contact857-203-6500
  • St. Louis VA Medical Center John Cochran Division, St. Louis, MO
    St Louis, Missouri 63106-1621, United States
    Recruiting
    • Jason Napuli, DC · Contact314-652-4100
  • VA Southern Nevada Healthcare System, North Las Vegas, NV
    North Las Vegas, Nevada 89086, United States
    Terminated

    Not enrolling at this site.

  • Asheville VA Medical Center, Asheville, NC
    Asheville, North Carolina 28805-2576, United States
    Recruiting
    • James Michalets, MD · Contact828-298-7911
  • VA Portland Health Care System, Portland, OR
    Portland, Oregon 97207-2964, United States
    Recruiting
    • Stephanie K Liu, MD · Contact503-220-8262
  • South Texas Health Care System, San Antonio, TX
    San Antonio, Texas 78229-4404, United States
    Recruiting
    • Michelle Trbovich, MD · Contact210-818-4353
  • VA Salt Lake City Health Care System, Salt Lake City, UT
    Salt Lake City, Utah 84148-0001, United States
    Recruiting
    • Patrick Powers, MD · Contact814-571-1608
  • Hampton VA Medical Center, Hampton, VA
    Hampton, Virginia 23667, United States
    Terminated

    Not enrolling at this site.

  • Hunter Holmes McGuire VA Medical Center, Richmond, VA
    Richmond, Virginia 23249-0001, United States
    Terminated

    Not enrolling at this site.

08

References and documents

Publications

  • Clark JD, Bair MJ, Belitskaya-Levy I, Fitzsimmons C, Zehm LM, Dougherty PE, Giannitrapani KF, Groessl EJ, Higgins DM, Murphy JL, Riddle DL, Huang GD, Shih MC. Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response (SCEPTER), a pragmatic trial for conservative chronic low back pain treatment. Contemp Clin Trials. 2023 Feb;125:107041. doi: 10.1016/j.cct.2022.107041. Epub 2022 Dec 7. PubMed 36496154 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2022 (actual). Primary completion is estimated for Jun 2027, 60 months after the start.

Of 1,234 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 26. This study's planned 60 months is above that.

Counting every sponsor, half of 1,290 studies reached it within 11 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 25, 2019
First posted
Oct 29, 2019
StartActual
Jun 13, 2022
Primary completionEst.
Jun 30, 2027
CompletionEst.
Jun 30, 2027
Last update
May 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04142177
Responsible party
Sponsor
First posted
Oct 29, 2019
Start date
Jun 13, 2022
Primary completion
Jun 30, 2027 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
May 4, 2026

Study contacts

Brandon J Stevenson, MSW BS
Contact
Brandon.Stevenson@va.gov
(319) 388-0581 ext. 3870
David J Clark, PhD MD
study chair · VA Palo Alto Health Care System, Palo Alto, CA
Matthew J. Bair, MD MS
study chair · Richard L. Roudebush VA Medical Center, Indianapolis, IN

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion